Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2001
03/21/2001CN1287836A Doukey-hide gelatin capsule
03/21/2001CN1287835A Medical ointment for periodontal disease
03/21/2001CN1063438C Alkenyl-benzoyl guanidine derivant, prepn. method and use thereof
03/21/2001CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound
03/21/2001CN1063337C Chinese medicine preparation for stomatocace
03/21/2001CN1063336C Tincture for treatment of toothache
03/20/2001US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same
03/20/2001US6204278 Anilide compounds, including use thereof in ACAT inhibitition
03/20/2001US6204055 Antisense inhibition of Fas mediated signaling
03/20/2001US6204015 Aminopeptidase from staphylococcus aureus
03/15/2001WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells
03/15/2001WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
03/15/2001WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
03/15/2001WO2001018203A1 Opg fusion protein compositions and methods
03/15/2001WO2001018172A2 Fibroblast growth factor-like polypeptides
03/15/2001WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies
03/15/2001WO2001018040A2 Use of leptin in inhibition of endothelial cell proliferation
03/15/2001WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies
03/15/2001WO2001017989A2 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists
03/15/2001WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
03/15/2001WO2001017963A2 Aminoalkoxy carbazoles and their use as 5-ht ligands
03/15/2001WO2001017954A1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same
03/15/2001WO2001017510A1 Agent for stimulating bowel function and method for producing the same
03/15/2001WO2001017509A1 Method for improving and maintaining bowel function as well as a method for the production thereof
03/15/2001WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery
03/15/2001WO2001017377A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
03/15/2001WO2001017364A1 Food product and process for manufacturing same
03/15/2001WO2000064468A3 Therapeutic compositions and methods for enhancing angiogenesis
03/15/2001WO2000061604A3 Pharmaceutical compounds
03/15/2001WO2000059469A3 Endodontic fibers and methods of use therefor
03/15/2001WO2000047196A3 Use of statins for treating viral infections
03/15/2001WO2000014263A8 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
03/15/2001DE19943815A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen
03/15/2001DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties
03/15/2001DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties
03/15/2001DE19943491A1 Verbesserte Komprimate Improved compressed
03/15/2001DE19943488A1 Agent for the treatment and prevention of pigeon diseases contains colony-producing lactobacilli
03/15/2001DE19941764A1 Substituierte Acylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika sowie sie enthaltende Medikamente Substituted acylguanidines, processes for their preparation, their use as medicaments or diagnostics and drugs containing them
03/15/2001DE19941217A1 Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben Treatment of migraine by administration of alpha-lipoic acid or derivatives thereof
03/15/2001DE19940944A1 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms
03/15/2001DE10014639A1 cDNSen mit einer Kodierung von Enzymen zur Fructan-Synthese mit einer Niedertemperatur-Expression sowie Verfahren zu deren Isolierung cDNSen with a coding for enzymes of fructan synthesis with a low-temperature expression as well as methods for their isolation
03/15/2001CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies
03/15/2001CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery
03/15/2001CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies
03/15/2001CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
03/15/2001CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
03/15/2001CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
03/15/2001CA2384046A1 Method for improving and maintaining bowel function as well as a method for the production thereof
03/15/2001CA2383996A1 Agent for stimulating bowel function and method for producing the same
03/15/2001CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells
03/15/2001CA2383774A1 Fibroblast growth factor-like polypeptides
03/15/2001CA2383729A1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same
03/15/2001CA2383578A1 Food product and process for manufacturing same
03/15/2001CA2383523A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
03/15/2001CA2380763A1 Aminoalkoxy carbazoles for the treatment of cns diseases
03/15/2001CA2349207A1 Opg fusion protein compositions and methods
03/14/2001EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid
03/14/2001EP1082960A2 Use of CRF antagonists and related compositions for treating depression and modifying the circadian rhytm
03/14/2001EP1082959A1 NK1 Antagonists for the treatment of depression
03/14/2001EP1082456A1 Antisense modulation of cd40 expression
03/14/2001EP1082320A1 Novel substituted imidazole compounds
03/14/2001EP1082302A1 A vla-4 inhibitor: omepupa-v
03/14/2001EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
03/14/2001EP1082120A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
03/14/2001EP1082114A1 Hydroxyomeprazole compositions and uses
03/14/2001EP1082103A1 Spill resistant pharmaceutical compositions
03/14/2001EP0675730B1 Therapeutic combination containing interferon
03/14/2001CN1287555A N-oxides of heterocyclic compounds with TNF and PDE IV inhibiting activity
03/14/2001CN1287008A Achyranthis bidentatae glycopeptide and its preparation
03/14/2001CN1286999A Veterinary medicine
03/14/2001CN1286998A Gastroenteritic disease treating medicine and its preparation
03/14/2001CN1286996A Sucked Chinese medicine preparation for treating gastropathy
03/14/2001CN1286993A Medicine for treating digestive tract diseases
03/14/2001CN1286988A Nourishing health granule
03/14/2001CN1286987A Kidney invigorating and Yin nourishing oral liquid
03/14/2001CN1286986A Kidney invigorating and Yin-nourushing syrup
03/14/2001CN1286983A Muscle and joint relaxing capsule
03/14/2001CN1286981A Inflammation diminishing and stone dissolving and exhausting liquid and its production process
03/14/2001CN1286980A Honey injecta and its preparation
03/14/2001CN1286978A Application of dimethyl silicone oil for treating ulcer colonitis
03/14/2001CN1286936A New-type health food capable of refreshing and relieving fatigue
03/14/2001CN1063180C 5H, 10H-imidazo [1,2-a] indeno [1,2-e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
03/14/2001CN1063176C Chromone derivative
03/14/2001CN1063088C Gandanzhi-Chinese herbal medicine for treating liver and gallbladder disorder
03/14/2001CN1063071C Powder medicine for strengthening spleen and softening liver
03/14/2001CN1063064C Medicine for curing peptic ulcer
03/14/2001CN1063063C Powder for curing hepatitis B
03/13/2001USRE37094 Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
03/13/2001US6201130 N-arylsulfonylamino acid omega-amides
03/13/2001US6201115 Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications
03/13/2001US6201025 For treatment of central nervous system disorders
03/13/2001US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction
03/13/2001US6201014 Unit dosage form of capsaisin or resiniferatoxin in admixture with a carrier for drug delivery to intestines to treat gastrointestinal disorders
03/13/2001US6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
03/13/2001US6201004 Dioxino derivatives and their use as therapeutic agents
03/13/2001US6200993 Heterosubstituted pyridine derivatives as PDE4 inhibitors
03/13/2001US6200991 Imidazole derivatives, preparation and therapeutic application thereof
03/13/2001US6200979 Administering substituted pyrazoles and pyzazolopyrimidines for treating phobias obsessive-compulsive disorder, post-traumatic stress disorder, single episode depression, recurrent depression, dysthymia, bipolar disorders
03/13/2001US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics
03/13/2001US6200957 Useful for treatment of variety of sex-hormone related and other conditions in both men and women